Answers are grounded in this paper and cite their sources.
The serum level of Krebs von den Lungen-6 (sKL-6) is a biomarker of interstitial pneumonia and has been reported to be elevated in patients with cancers. However, there have been few cases of gastric cancer (GC) with elevated sKL-6 that were treated by chemotherapy. We herein report two cases of GC with elevated sKL-6 that were treated with oxaliplatin plus S-1 (SOX) chemotherapy and discussed the resulting changes in sKL-6.
No takes yet. Share an insight, caveat, or question.
Yanagisawa et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: